Background: Fluid management is a major factor determining perioperative outcome, yet in reality, fluid administration practice is variable. Thirst however, is a highly sensitive and reliable indicator of fluid deficits. We explored the use of thirst sensation to trigger i.v. fluid boluses to guide individualized fluid management. Methods: We performed a randomised double crossover trial on 16 healthy male volunteers, of mean age 31 yr and BMI 24.4 kg m À2 . Twice, after administrations of oral furosemide (40 mg) and 12 h of oral fluid restriction, participants
Dehydration is associated with an increased risk of suffering acute kidney injury, 1 myocardial infarction, 2 venous thromboembolism, 3 and delirium. 4 By contrast, iatrogenic fluid overload is associated with an array of clinical risks including pulmonary and gut wall oedema, intestinal ileus, impaired coagulation, urinary retention, and impaired stroke volume. 5 Thus, both excessively restrictive and liberal fluid administration may be associated with harm. 6, 7 Careful fluid management, which maintains euvolaemia throughout the perioperative period minimizes gut injury, facilitating early oral fluid intake, and mobilization in line with enhanced recovery pathways. 8, 9 Goal directed fluid therapy, guided by measurements of stroke volume variation, cardiac output, and pulse contour analysis, can reduce both postoperative morbidity and length of stay. 7, 10 This intensive monitoring is mostly reserved for the highly-regulated environment of the operating theatre or high-dependency unit, while at other points in the perioperative period, no single gold standard test exists that accurately indicates hydration status. 11 The commonly used clinical features of dehydration represent a poor guide to fluid administration, only appearing when fluid losses exceed 4e5%. 12, 13 The diagnosis of dehydration based on clinical signs is therefore unreliable, with very low sensitivity of between 0 and 44%, and poor specificity. 14 Consequently, perioperative fluid management is often highly variable and suboptimal, 15 often delegated to junior staff while physical access to oral fluids is limited. 16 While there is substantial literature regarding perioperative goal directed therapy, the same meticulous investigation has not been applied to broader ward-based settings. Elevated plasma osmolality (pOsm) may represent the best objective index of dehydration in hospitalized patients, 17 with a value >295 mOsm kg À1 increasingly selected as a defining reference for dehydration. 18 In adults across all ages, and in both sexes, there exists a specific threshold value of pOsm, above which central osmoreceptors linearly increase the sensation of thirst. 19e24 The thirst response is also stimulated by reductions in intravascular volume. The reduced renal artery baroreceptor activity stimulates thirst by increasing serum angiotensin II, 25 while reduced atrial and pulmonary arterial baroreceptor activity stimulates thirst either through reductions in tonic atrial natriuretic peptide release 26 or through a shared vagal and glossopharyngeal pathway. 27 This baroreceptor pathway converges with afferents from central osmoreceptors on the hypothalamic thirst centre. Reductions in intravascular volume interact synergistically with increase in pOsm to drive thirst. 28 The stimulation of thirst occurs in response to an integration of physiological parameters and could provide valuable feedback pertaining to a patient's overall fluid balance. Patient-controlled analgesia systems have successfully demonstrated the effectiveness of utilizing subjective discomfort to titrate an i.v. analgesic therapy. 29 Therefore, we hypothesize that the sensation of thirst could similarly be used as a guide to titrate i.v. fluid therapy within strict upper limits. As the first step in testing this hypothesis, we performed a randomised controlled double crossover study on healthy adult volunteers. This laboratory-based early feasibility study serves as a precursor to a clinical feasibility study in perioperative setting.
Methods
The study was completed with local institutional (University College London, UCL) research Ethics Committee approval (Ref. 9339-001). All participants provided written, informed consent before the study. Inclusion criteria were: males aged 18e65 yr, ASA physical status I, body mass between 55 and 100 kg and not on regular medication.
Dehydration protocol
Participants avoided strenuous exercise for 48 h before each trial. Participants were instructed to take 40 mg of the oral loop diuretic, furosemide at 20:00 h the evening before the study, and then to abstain from all fluid, food, and caffeine intake until the end of study. Participants completed this dehydration protocol on two occasions, 7e14 days apart (Fig. 1) . Participants were requested to record their pre-diuresis body mass where possible.
Rehydration protocol
Participants attended our laboratory at 08:00 h on the morning after their diuresis and fluid restriction. On arrival, participants provided an initial urine sample, and their height and weight were documented. Having lain recumbent for 15 min, an 18 G cannula was placed in a large forearm vein, from which a 5 ml blood sample was drawn. 19 A balanced electrolyte solution (4% glucose in 0.18% sodium chloride) was then administered via an Infusomat® Space volumetric pump (B Braun, Melsungen, Germany) over 4 h. At the start of the infusion, and at 60 min intervals thereafter, participants were weighed and asked to mark a 125 mm visual analogue subjective thirst scale (ranging from 'not thirsty' to 'extremely thirsty') 19 : dividing the distance marked by 12.5 mm gave a thirst score out of 10. At the end of the 4-h trial, a second 5 ml blood sample was obtained. Participants voided their bladder 30 min before the end of trial and a final urine sample was obtained at the end of the trial. Urine samples were immediately analysed for specific gravity with Multistix Reagent Strips (Siemens, Berlin, Germany). Blood samples from the beginning and end of the trial were collected into serum separating tubes and immediately centrifuged; 1.5 ml of serum were obtained and frozen at À82 C, and later analysed for pOsm by a blinded investigator using freezing point depression (3320 Osmometer: Advanced Instruments, Northwood, MA, USA).
In an unblinded, randomised double crossover design trial, one of two infusion protocols was used at each visit, the order being determined by block randomization using the R 'blockrand' package. 30 
Editor's key points
In a randomised crossover trial, the authors assessed whether fluid administration based on thirst sensation would be better than the current method recommended by NICE guidelines. A system delivering i.v. fluid in response to subjective thirst was better than the conventional method in correcting fluid deficits without causing fluid overload in healthy participants.
In the control arm of the trial, according to the National Institute for Health and Clinical Excellence guidelines for a patient with an unknown fluid deficit, 16 participants received a continuous infusion of i.v. fluid at a rate of 1.25 ml kg À1 h À1 . Participants were examined for signs of hypovolaemia: prolonged capillary refill time (>2 s), reduced skin turgor, systolic blood pressure of <90 mm Hg and heart rate of >100 beats min À1 . If any of these signs were observed, a clinician triggered bolus of 500 ml i.v. fluid would be administered at a rate of 1200 ml h À1 .
In the experimental arm of the trial, participants received thirst-based self-administrated i.v. fluid boluses. Participants were instructed to activate a hand-held trigger to relieve their thirst. In response to this trigger, linked to a laptop computer, an auditory alarm sounded and a 200 ml fluid bolus was delivered. Data relating to time and volume infused were directly stored in data handling software, R (R Foundation for Statistical Computing, Vienna, Austria). Cannula patency was maintained by a background infusion rate of 1 ml h À1 .
Data handling
Statistical power calculations were estimated with equivalence limits for the difference in volume administered set at 750 ml, with a hypothesized standard deviation (SD) of 1000 ml. To achieve a 5% significance level and 80% power for a two tailed t-test between dependant means, it was calculated that a total sample size of 16 was required. The primary outcome measure was the difference in the volume of i.v. fluid administered over the course of each infusion. As secondary outcome measures, differences in urine specific gravity, pOsm, and subjective thirst score between the beginning and the end of each infusion were compared between the two arms of the trial for each participant.
The data for volume administered were normally distributed and were thus analysed using a paired t-test. Additionally, the volumes administered over time were logged and fitted to an exponential model in R. Urine specific gravity and pOsm were compared with a paired t-test. Subjective thirst data were not normally distributed and so were compared with a Wilcox signed rank test.
Results
Of 19 participants who volunteered for our study, two did not meet inclusion criteria, and one participant dropped out because of time constraints. Thus, 16 participants were studied [mean age 31 (8.7) yr, height 181 (6) cm, weight 79 (11.9) kg, and BMI 24.4 (4.5) kg m À2 ]. The self-reported pre-diuresis body masses of eight participants estimate a total body water loss as a result of our dehydration protocol of between 1and 1.5 litres.
Volume of fluid administered
No participants required additional fluid administration based on clinical examination. One participant in the experimental arm suffered a brief vasovagal response to cannula placement, which was not treated with fluids and from which they rapidly and spontaneously recovered. Participants in the experimental arm who controlled their own administration of i.v. fluids received 1138 (424) ml. This was significantly greater than the 394 (61) ml received in the Fig 1. A diagram of the movement of participants through our experiment. Participants moved from left to right, passing into either the experimental or control arm, before repeating the protocol in the opposite arm of the trial between 7 and 14 days later. (Fig. 2) . In keeping, measurements of the participants' body mass showed a mean increase in the experimental arm of 1142 g (440 g), with 77.3% (15.1%) of this increase occurring over the first 120 min of the infusion.
Physiological parameters
A larger reduction in urine specific gravity and subjective thirst score was seen over the course of the experimental arm, with mean difference of 0.0053 kg m À3 (P¼0.002) and 3.3 (2.8) (P¼0.0034) (Fig. 3) . Whilst numerically larger reductions in pOsm were associated with the experimental arm, this difference (mean 1.9 mOsm kg À1 ) was not statistically significant.
Discussion
The graph of volume administered against time (Fig. 2) demonstrates the performance of the experimental arm as compared with the control arm. Clinical signs of dehydration lacked the sensitivity to detect the 1e1.5 litres of fluid loss experienced by the participants. No additional fluid boluses were administered in the control arm (Fig. 2, red) , and therefore it appears graphically as a continuous infusion varying only with each participant's body mass. In the experimental arm (Fig. 2, green) , participants quickly selfadministered i.v. fluid over the first 2 h of the study, largely correcting their fluid deficit. This is reflected by the high proportion (77.3%) of the body mass increase measured, occurring in the first 120 min of the study and is consistent with participants reducing their rate of i.v. fluid administration as the sensation of thirst subsided in response to rehydration. The volumes administered V in the experimental arm were fitted to an exponential function of time t:
F A and F B each approximate to the total volume administered in each participant. This function can be applied to each participant's infusion individually or to the cohort as a whole (Fig. 2B ). The decay constant k for each participant corresponds to a mean half-life of 98.8 (65.2) min. This half-life of thirst-driven fluid administration allows for correction of the fluid deficit, after two half-lives. This represents an acceptable timeframe to continue i.v. fluid therapy after major surgery, especially in those patients with impaired oral intake. Our participants reduced their frequency of i.v. boluses triggering, after infusion of i.v. fluid and an exponential reduction in subjective thirst scores (Fig. 4) . The thirst scores (S) in the experimental arm can be fitted to a similar function of time t, as above:
U A and U B each approximate to the initial thirst intensity before rehydration. The similarity of these two functions, which correspond very closely to the raw data, suggests that the sensation of thirst is responsive to rehydration in the time domain; this is essential in avoiding volume overload. There are several potential mechanisms underlying this responsiveness. The reduction in pOsm, towards the threshold of thirst activation, reduces the frequency of osmoreceptor depolarization. 31 Additionally, the restoration of intravascular volume relieves the additional potentiation of osmoreceptorstimulated thirst, caused by the convergent baroreceptor pathway. 28 The inhibition of thirst caused by the tonic release of atrial natriuretic peptide, stimulated by normal atrial filling, also contributes to the appropriate subsidence of thirst as intravascular volume is restored. 26 A mean final pOsm of 283.8 mOsm kg À1 after the experimental infusion is consistent with results from previous trials 19e23 which investigated the pOsm threshold for thirst sensitization. In our study, the lowest final pOsm for any participant was 275 mOsm kg À1 and no participants had a pOsm outside of the normal reference range. High urine specific gravity is indicative of dehydration, as arginine vasopressin increases the reabsorption of water at the distal convoluted tubule and collecting duct. 32 The reductions in this parameter demonstrate the correction of dehydration.
Values of pOsm were affected by the administration of furosemide, a loop diuretic, which blocks the reabsorption of sodium and potassium in the thick ascending limb of the loop of Henle. 33 The resulting natriuresis led to a lower starting pOsm than would be seen in the pure water loss dehydration more prevalent in the clinical setting, which follows prolonged fasting and use of bowel preparation. Therefore, our study is limited in that the increase in pOsm after diuresis was of a smaller magnitude than would be seen in perioperative dehydration. However, because of the synergistic sensitization of the osmotic thirst response by the hypovolaemic thirst response, a significant thirst stimulus existed to drive fluid administration. Many different experimental protocols have been used by others in order to induce dehydration: exercise, thermal challenge, fluid intake restriction, or diuretic administration. In the case of furosemide, of course, the relative loss of body sodium is vastly less than the relative loss of body water, meaning that an isolated challenge such as this does lead to primarily water-loss dehydration, and in this respect our model is clinically relevant. However, where electrolyte deficits exist, additional supplementation might be considered in further studies. The first clinical feasibility study will assess the thirst response in the context of clinical dehydration. It must be noted that the 4% glucose 0.18% sodium solution used had an osmolality of 282 mOsm kg À1 , which is below the threshold for thirst stimulation. If a hypertonic, salt rich solution, such as 'normal' saline, was used in this trial, there would have been an increase in osmotic thirst throughout the infusion, with a risk of volume overload. Whilst furosemide induces water and salt loss, the relative impact on body salt content would have been trivial when compared with the impact on body water. Thus, we chose to use an electrolytepoor solution for rehydration, with a sodium concentration four times lower than that of Ringer's lactate. The exact bolus volume delivered is likely to subtly affect the performance of this system. Changes in thirst do not occur immediately with rehydration, and therefore larger bolus sizes increase the risk of 'overshooting' the point of zero thirst. Conversely, very small fluid boluses may cause a patient to find the system ineffective, and would require excessively frequent triggering to achieve euvolaemia. In this case, a 200 ml bolus, similar to a small glass of water, was chosen as a volume which was likely to be effective and representative of a normal response to thirst. This relatively large bolus size carries a hypothetical risk of upwardly skewing the volumes in the experimental arm. However, it can be seen from Fig 2A that in many cases the final volume was five to eight times larger than the bolus size, demonstrating that the final volume administered was determined by bolus frequency rather than bolus size. The average bolus frequency was much lower than the maximum dictated by the 15 min lockout period; it can be concluded that participants had adequate scope to have either administered more or less fluid, independent of bolus size.
Our findings are consistent with previous work on the clinical signs of dehydration, in demonstrating that these signs have low sensitivity for sub-severe degrees of fluid loss. 14 Our study also confirms that thirst is highly sensitive in detecting small variations from euvolaemia. While previous trials focused on purely osmotic stimulation of thirst, with starting osmolalities as high as 310 mOsm kg À1 , our study demonstrates the sensitivity of thirst to mild degrees of hypertonicity and mild fluid deficit.
18e22 Most significantly, this trial demonstrates the responsiveness of thirst in the time domain to i.v. rehydration; this is an essential safety aspect of a thirst-driven fluid administration system. There were, however, several areas of weakness in this trial. Firstly, the study was not blinded. In the absence of a urinary catheter, participants could not be blinded to the administration of furosemide. Had control arm participants been given an ineffective thirst trigger in an effort to blind to the experimental arm, its lack of efficacy might have impacted trigger use in the experimental arm. It is difficult to blind to the administration of fluid as participants are able to sense fluid passing into a vein. Further studies might, however, address whether this sensation might be minimized by accurate warming, and whether double-blinding might be achieved by altering the size and rate of bolus administration. Serial measurements of euvolaemic body mass were not available for each participant, and as such the specific level of fluid deficit in each individual was not known. This is more representative of patients presenting to hospital and accounts for the difference in total volume administered by each participant. It is a weakness of this study that the degree of dehydration engendered by diuretic administration was not quantified for each participant. At the time of taking the diuretic, individuals were naturally in a variable state of water balance; differences in renal artery flow thus impacted the effect of the diuretic. This variability, however, reflected by the relatively large SDs in our results. Ideally, future studies might utilize serial measurements of daily weights, urine specific gravity, and pOsm measurements such that the impact of the administered diuretic might be better described.
Our findings should be cautiously interpreted across different patient groups. The responsiveness of thirst to changes in fluid balance over short periods of time also varies with age, gender, and effects of medications. 20 It has been established that the elderly drink less water in response to a fluid deficit. However, owing to the independent thirstinhibiting action of oropharyngeal osmoreceptors when drinking, it is not yet known if this reduced intake will be seen with i.v. rehydration. This will be a particular focus of further work, in which adjustment of bolus volumes and rates will be investigated as means of compensating for reduced thirst intensity. In pregnancy and in the luteal phase of the menstrual cycle, thirst threshold decreases. 34 In the clinical setting high doses of morphine appear to stimulate drinking whilst low doses may inhibit the sensation of thirst. 35 Despite the stimulating effect of angiotensin II on thirst activation, no changes are seen in thirst rating in response to pain. 36 In conclusion, our study suggests that thirst is sensitive to mild dehydration and appropriately subsides with i.v. rehydration. The administration of hypotonic i.v. fluid, titrated against the subjective thirst response of a healthy participant, will allow for restoration of approximate euvolaemia, after two half-lives, in an acceptable timeframe of 1e6 h. These findings support the study hypothesis that thirst-directed patient-controlled fluid administration may be feasible as an adjunct to standard therapy. This warrants further investigation in the perioperative setting. We propose a clinical feasibility study of closely supervised patient-controlled fluid administration in the postoperative period. Additionally, the exponential function to which the experimental infusions are fitted is plotted in black. The exponential decrease in thirst in the experimental arm corresponds to the exponential decrease in infusion rate seen in Fig. 2 .
